miRNA-20a在膀胱癌中的表達(dá)及其機(jī)制研究
[Abstract]:Objective: to investigate the expression and mechanism of miRNA-20a in bladder cancer. Methods: from January 2014 to January 2015, 96 tissue specimens from the second affiliated Hospital of Kunming Medical University were collected and the expression of miRNA-20a in bladder cancer and adjacent tissues was detected by real-time quantitative polymerase chain reaction (Q RT-PCR). Bioinformatics method was used to predict the target gene of miRNA-20a, and double luciferase reporter gene assay was used to verify the expression of miRNA-20a mimics or negative control in human bladder cancer cell lines T24 and J82, respectively, by using double luciferase reporter gene assay and immunofluorescence assay. The expression of target gene mRNA and protein was affected by CCK-8 transwell invasion chamber and scratch assay was used to detect the proliferation of T24 cells after overexpression of miRNA-20a in vitro. Changes in migration and invasiveness. Results the expression of 10 miRNA-20a was highly expressed in bladder cancer tissues, and was correlated with the pathological grade and clinical stage of the tumor. There was a close correlation between metastasis and recurrence (P0.001), double luciferase reporter gene experiment confirmed that miRNA-20a was directly targeted to the 3'-UTR of human longevity guarantee gene 2 (Homo sapiens longevity assurance homologue 2 / LASS2. Transfection of miRNA-20a mimics could significantly down-regulate the expression of LASS2 m RNA and protein in bladder cancer cells (P0.01), and enhance the proliferation, invasion and migration of bladder cancer cells (P0.01). ConclusionMmiRNA-20a is highly expressed in bladder cancer tissues, and miRNA-20a can promote the proliferation, invasion and migration of bladder cancer cells by targeting the inhibition of LASS2, which is related to the occurrence and development of bladder cancer.
【作者單位】: 昆明醫(yī)科大學(xué)第二附屬醫(yī)院泌尿外科云南省泌尿外科研究所;云南省楚雄州人民醫(yī)院新區(qū)腎臟內(nèi)科;
【基金】:國(guó)家自然科學(xué)基金項(xiàng)目(編號(hào):81460384) 云南省科技計(jì)劃項(xiàng)目(編號(hào):2015FB196) 云南省教育廳科學(xué)研究基金項(xiàng)目(編號(hào):2014Z072)資助~~
【分類(lèi)號(hào)】:R737.14
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 嘉勉;膀胱癌基因被確認(rèn)[J];遼寧醫(yī)學(xué)雜志;2004年03期
2 青云;英國(guó)科學(xué)家辨別出與膀胱癌有關(guān)的基因[J];中國(guó)處方藥;2004年08期
3 ;特殊激素可導(dǎo)致男性患膀胱癌幾率升高[J];中國(guó)社區(qū)醫(yī)師(綜合版);2007年11期
4 丁虹彬,余雪軒;培養(yǎng)膀胱癌細(xì)胞的新方法[J];南京醫(yī)學(xué)院學(xué)報(bào);1994年01期
5 張曉峰;劉訓(xùn)勤;;一種新型膀胱癌快速診斷裝置[J];醫(yī)療衛(wèi)生裝備;2013年10期
6 孫宏志,凡杰,唐孝達(dá);自穩(wěn)定反義IGF1R基因片段對(duì)膀胱癌細(xì)胞的影響[J];中華泌尿外科雜志;2000年05期
7 章小平,楊紅枚,魯功成;膀胱癌穩(wěn)定表達(dá)多藥耐受相關(guān)蛋白亞克隆的生物學(xué)特征[J];中華實(shí)驗(yàn)外科雜志;2000年03期
8 漆少廷,徐錫坤,王心如;膀胱癌的分子生物學(xué)研究進(jìn)展[J];國(guó)外醫(yī)學(xué).泌尿系統(tǒng)分冊(cè);2000年04期
9 章小平,楊紅枚,魯功成;流式細(xì)胞儀在膀胱癌多藥耐受研究中的應(yīng)用[J];臨床泌尿外科雜志;2000年09期
10 楊莉,汪少娟,楊業(yè)金,陳忠,吳燕麗;抗腫瘤藥對(duì)膀胱癌細(xì)胞產(chǎn)生的免疫抑制因子作用的影響[J];藥物流行病學(xué)雜志;2000年03期
相關(guān)會(huì)議論文 前10條
1 張永春;谷江;孫發(fā);石家齊;;傳統(tǒng)醫(yī)學(xué)在膀胱癌治療中的意義[A];2010年貴州省泌尿外科學(xué)術(shù)會(huì)議論文集[C];2010年
2 潘春武;沈周俊;唐小瑩;王e,
本文編號(hào):2230443
本文鏈接:http://www.wukwdryxk.cn/yixuelunwen/mjlw/2230443.html